These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33929085)

  • 1. Direct healthcare professional communications: A quantitative assessment study.
    Alsaleh H; Alshammari TM
    Pharmacol Res Perspect; 2021 May; 9(3):e00763. PubMed ID: 33929085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
    Boskovic A; Møllebæk M; Kaae S
    Ther Innov Regul Sci; 2020 May; 54(3):631-639. PubMed ID: 33301149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
    Boskovic A; Møllebæk M; Kaae S
    Ther Innov Regul Sci; 2019 Sep; ():2168479019871041. PubMed ID: 31510799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences.
    de Vries ST; van der Sar MJM; Cupelli A; Baldelli I; Coleman AM; Montero D; Šipić I; Andrić A; Wennberg A; Ahlqvist-Rastad J; Denig P; Mol PGM;
    Drug Saf; 2017 Aug; 40(8):729-742. PubMed ID: 28540672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of direct to healthcare professional communication - A systematic review of communication factor studies.
    Møllebæk M; Kaae S; De Bruin ML; Callréus T; Jossan S; Hallgreen CE
    Res Social Adm Pharm; 2019 May; 15(5):475-482. PubMed ID: 31130181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron.
    Moriarty F; Razzaque S; McDowell R; Fahey T
    J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30282903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacovigilance system in Saudi Arabia.
    Alshammari TM; Alshakka M; Aljadhey H
    Saudi Pharm J; 2017 Mar; 25(3):299-305. PubMed ID: 28344483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.
    Getova VI; Georgiev SR; Stoimenova AH; Petkova-Georgieva ES
    Folia Med (Plovdiv); 2018 Sep; 60(3):447-453. PubMed ID: 30355838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.
    Piening S; de Graeff PA; Straus SM; Haaijer-Ruskamp FM; Mol PG
    Drug Saf; 2013 Sep; 36(9):723-31. PubMed ID: 23797603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saudi Vigilance Program: Challenges and lessons learned.
    Alharf A; Alqahtani N; Saeed G; Alshahrani A; Alshahrani M; Aljasser N; Alquwaizani M; Bawazir S
    Saudi Pharm J; 2018 Mar; 26(3):388-395. PubMed ID: 29556130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
    Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; de Graeff PA; Mol PG
    Drug Saf; 2011 Nov; 34(11):1101-14. PubMed ID: 21981437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands.
    de Vries E; Denig P; de Vries ST; Monster TBM; Hugtenburg JG; Mol PGM
    Drug Saf; 2020 Jul; 43(7):677-690. PubMed ID: 32212054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.
    Aljadhey H; Mahmoud MA; Alshammari TM; Al-Dhaeefi M; Le Louet H; Perez-Gutthann S; Pitts PJ
    Saudi Med J; 2015 Sep; 36(9):1097-102. PubMed ID: 26318468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonization of Pharmacovigilance Regulation in Brazil: Opportunities to Improve Risk Communication.
    Varallo FR; Forgerini M; Herdeiro MT; de Carvalho Mastroianni P
    Clin Ther; 2019 Mar; 41(3):598-603. PubMed ID: 30792075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Enigma of Pharmacovigilance of Patient Support Programs: A Survey of Marketing Authorization Holders in Europe.
    Portnoff JM; Lewis DJ
    Ther Innov Regul Sci; 2017 Jul; 51(4):486-493. PubMed ID: 30227052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
    Mol PG; Straus SM; Piening S; de Vries JT; de Graeff PA; Haaijer-Ruskamp FM
    Drug Saf; 2010 Jun; 33(6):463-74. PubMed ID: 20486729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.